Company
There are few opportunities to have an impact on so many.
Our Vision
To cultivate a symbiotic relationship between AI and humans, fostering a deeper understanding of our universe, promoting mental and physical well-being, and ensuring a sustainable future for our planet and beyond.
Mission
Alevra aims to create a safe, responsible, and ethical environment for AI-human interactions within the healthcare industry. We strive to leverage AI technology and private health data to facilitate personalized health solutions, while advocating for a harmonious coexistence between humans and AI, ultimately contributing to the betterment of our global community.
Advisors
Peter Stockmann
CEO
The Areopa Group
Leading a globally recognized Intellectual Capital Consulting Firm at Areopa, Peter maximizes the intrinsic value of Alevra’s solutions.
Robert Whitehair
CEO
Eumonics
As a formative voice, researcher and expert on Machine Learning, Bob brings a guide forcing to Alevra. His ingenuity, mathematical ability, and ML-industry experience will assist Alevra to translate various layers of technology into beneficial, deployable and predictable solution sets.
Martin Garden
AI Health Sector Senior Software Engineer
Microsoft
Understanding, knowing & recognizing Best Practice Philosophies is a critical component Martin brings to Alevra.
Dr. Thomas Boyd
Dean of Business and Management
Kaplan University
Tom understands how business processes and strategy all should fit and flow together to ensure a clear, solid and sound message is not only conveyed but also delivered. He brings the necessary expertise that holds us accountable in a strategic manner.
Greg Duffell
CEO & Director
Vulcain Inc.
As a Global Markets Guru, Greg understands how Alevra’s offerings fit within these markets. He brings invaluable insight into the predictable human analytical marketplace.
Dr. Karthikeyan Ganapathy
Clinic Director
Envision Mind Care
Dr. Ganapthy’s pioneering vision, exceptional leadership skills, and advanced clinical expertise play an instrumental role in shaping the innovative landscape of the future of mental health care.
Company Background
Established in 2021, Alevra's roots can be traced back to earlier discussions between President and Founder, Merv Joseph, and Co-Founder, Shannon Routley. The company's vision evolved with the global pandemic, revealing the vast under-served needs of millions suffering from mental health issues including disorders such as Obsessive Compulsive Disorder (OCD).
As Alevra's understanding of the future of AI and human interaction deepened, our mission expanded to create a safe, responsible, and ethical environment that fosters a positive relationship between AI, customers and practicioners in the healthcare industry. This foundation has guided our continued growth and development as a company.
Our goal for 2023 is to expand the company's Board of Directors and Advisory Board. Together, these teams will spearhead fundraising activities, business planning, and operational structures needed to enter the market and make a lasting impact on the lives of millions worldwide.
Alevra represents a unique opportunity to be the first to market and redefine how a company can bring well-being to millions of people where traditional means have failed.
In an era where social media and tech startups face scrutiny, Alevra aims to be a breath of fresh air with its unwavering commitment to its audience and employees.
We strive to be the model and raise the bar for the next generation of health-based companies. By utilizing progressive practices that prioritize overall customer benefit, Alevra will differentiate itself and transcend strictly transactional models.
Our success depends on maintaining a culture of leadership, design, and integrity - one that will define the model for global health-based businesses and shape the future of AI-human engagement.
For investors and to learn more about our strategy click here.